Developer docs
API playgroundTry for free, no card

Search company profiles

NeuroCatch

Full company profile

uuid000c69d

Namestring
NeuroCatch
Legal namestring
NeuroCatch Inc.
Websiteurl
neurocatch.com
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSurrey, Canada
HQ citystring
Surrey
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
EEG medical device, cognitive brain assessment, event-related potentials, brain vital signs, neurophysiological monitoring
Industry4 codes
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAKAIAA
General Neurology
SECONDARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAFAKAK
Neurodiagnostic Centers (EEG/EMG/NCS)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Services-Prepackaged Software7372
Product category
Neurodiagnostic Medical Devices
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1NeuroCatch Platform Device Sales
TypeHardware Sales
Description

Sale of portable EEG-based medical device hardware to healthcare providers, clinicians, sports organizations, and military programs for cognitive assessment at point of care.

neurocatch.com
2Platform Software/Services
TypeSubscription Recurring
Description

Software platform services for cognitive brain function assessment. NeuroCatch Platform provided to healthcare providers for processing and analyzing neurological data.

neurocatch.com
3Clinical/Professional Services
TypeProfessional Services
Description

Clinical integration support and professional services for implementing brain vital signs assessments in clinical and performance settings.

neurocatch.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Pricing details1 tier
1Enterprise/Federal Healthcare Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Direct sales to federal healthcare systems including VHA, MHS, IHS. Available on government purchasing vehicles including VA Federal Supply Schedule (FSS), GSA Advantage, and DLA Electronic Catalog (ECAT).

neurocatch.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

NeuroCatch develops and sells the NeuroCatch Platform, a portable EEG-based medical device that delivers objective cognitive brain function assessments in approximately 6 minutes at the point of care. The platform measures three event-related potentials (N100, P300, N400) extracted from EEG signals to quantify auditory sensation, basic attention, and cognitive processing. It is sold to healthcare providers, federal healthcare systems, sports organizations, military programs, and corporate wellness buyers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Cognitive assessment completed in approximately 6 minutes at point of care
+2 more records
Product overview1 text field

NeuroCatch offers a single unified medical device product called the NeuroCatch Platform. This flagship platform is a portable EEG-based system that delivers rapid, objective cognitive assessments in approximately 6 minutes at the point of care. The platform measures three specific event-related potentials (ERPs) - N100 for auditory sensation, P300 for basic attention, and N400 for cognitive processing - providing healthcare professionals with quantitative brain vital sign metrics. The NeuroCatch Platform is intended to be used in conjunction with other cognitive assessments and is not a standalone diagnostic tool for a specific brain health condition.

Product and service1 record
1NeuroCatch Platform
CategoryNeurodiagnostic Medical Device
Description

A portable, non-invasive EEG-based medical device that provides rapid (approximately 6-minute) objective cognitive assessments using the Brain Vital Signs framework. It measures three event-related potentials (N100 for auditory sensation, P300 for basic attention, N400 for cognitive processing) and is intended to be used in conjunction with other cognitive assessments. Registered with the Australian Register of Therapeutic Goods (ARTG 439393) and designated Rx only in the US.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-09
Description

U.S. headquarters location at Phoenix Bioscience Core, a 30-acre medical and bioscience campus with Arizona's major universities, hospital systems, and research facilities. Supported by Greater Phoenix Economic Council (GPEC).

2XLR8 PBC (Phoenix Bioscience Core)
Strategic tierSupportingTypeStrategic or Co-development PartnerAnnounced on2025-09-10
Description

Selected for Fall 2025 cohort of XLR8 PBC, a strategic launchpad program supporting health tech companies with access to industry leaders, mentorship, and strategic resources. Part of Phoenix's growing bioscience and medtech ecosystem.

neurocatch.com
3Garibaldi Performance Center
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-09
Description

Partnership with Whistler's new premier human optimization facility to provide cognitive assessment services at Crankworx Whistler 2025. NeuroCatch provided baseline assessments and brain vital signs for elite downhill mountain bike riders including Aaron Gwin, Dakotah Norton, and Frida Ronning.

neurocatch.com
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-08-14
Description

Partnership with Service-Disabled Veteran-Owned Small Business (SDVOSB) to provide NeuroCatch Platform to major federal healthcare systems including Veterans Health Administration (VHA), Military Health System (MHS), and Indian Health Service (IHS). NeuroCatch Platform is now available on VA Federal Supply Schedule (FSS), GSA Advantage, and DLA Electronic Catalog (ECAT).

5HealthTech Connex Inc.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Related entity that developed the NeuroCatch Platform technology. Co-founder Dr. Ryan D'Arcy serves as President & CSO of both entities. HealthTech Connex operates the brain clinic where NeuroCatch technology was developed.

neurocatch.com
6ASU/Mayo MedTech Accelerator
Strategic tierSupportingTypeOthers
Description

NeuroCatch was an alumnus of the 2025 Arizona State University/Mayo Clinic MedTech Accelerator program, which helped advance the company's U.S. expansion and commercialization strategy.

neurocatch.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Kernel builds non-invasive brain-activity measurement hardware and cognitive performance tools. It is an emerging player in portable cognitive/neural monitoring and partially competes for the same premium cognitive performance and research buyers.

TypeEmerging player
Description

Muse sells a consumer EEG brain-sensing headband and accompanying meditation/cognitive apps. It is an emerging player in portable EEG with adjacent brain-health branding, but its regulatory pathway and customer base are consumer rather than clinical.

TypeEmerging player
Description

Emotiv builds consumer and research EEG headsets with associated cognitive and ERP analytics. It is an emerging player in portable EEG with overlapping neuroscience underpinnings, but skews toward consumer/wellness rather than clinical federal buyers.

TypeBroad incumbent
Description

ANT Neuro is an established provider of EEG, EMG, and TMS equipment and software for research and clinical neurophysiology. It is a broad incumbent in the same EEG/ERP measurement category but with a much larger product portfolio and enterprise research focus.

TypeBroad incumbent
Description

MindMaze develops digital neurotherapeutics and brain-computer interface platforms for neurological recovery and cognitive assessment. It is a broad incumbent working in adjacent neurological assessment and rehabilitation markets.

TypeDirect peer
Description

BrainScope develops EEG-based medical devices for objective assessment of traumatic brain injury and concussion in clinical and military settings. It directly competes with NeuroCatch in portable, point-of-care brain function assessment and shares the federal/military buyer profile.

TypeBroad incumbent
Description

Compumedics manufactures EEG, sleep diagnostic, and brain monitoring equipment sold globally to hospitals and researchers. It is a broad incumbent serving similar neurology and sleep customers with a wider hardware portfolio.

TypeDirect peer
Description

SyncThink markets eye-tracking and VR-based objective concussion and balance assessment tools used by sports teams and clinicians. It competes with NeuroCatch for the same sports and military concussion/cognitive readiness budgets.

TypeEmerging player
Description

Cumulus Neuroscience offers a cloud-enabled EEG platform that measures multiple cognitive biomarkers for clinical trials and CNS drug development. It overlaps with NeuroCatch on multi-ERP cognitive assessment but is more focused on pharma/biotech customers.

TypeDirect peer
Description

Advanced Brain Monitoring produces EEG-based systems for sleep, cognitive performance, and neurological conditions. It is directly comparable to NeuroCatch on portable EEG, ERP-based cognitive assessment, and sports/military use cases.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NeuroCatch

Neurodiagnostic Medical Devicesneurocatch.com

NeuroCatch firmographics

Firmographics
Name
NeuroCatch
Legal name
NeuroCatch Inc.
Website
https://neurocatch.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

NeuroCatch industry classification

Industry
Product category
Neurodiagnostic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAHACAE
Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAKAIAA
General Neurology
SECONDARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAFAKAK
Neurodiagnostic Centers (EEG/EMG/NCS)

Keywords

  • EEG medical device
  • Cognitive brain assessment
  • Event-related potentials
  • Brain vital signs
  • Neurophysiological monitoring

Where NeuroCatch is headquartered

Location

Headquarters

HQ city
Surrey
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

NeuroCatch business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. NeuroCatch Platform Device Sales: Sale of portable EEG-based medical device hardware to healthcare providers, clinicians, sports organizations, and military programs for cognitive assessment at point of care.
  2. Platform Software/Services: Software platform services for cognitive brain function assessment. NeuroCatch Platform provided to healthcare providers for processing and analyzing neurological data.
  3. Clinical/Professional Services: Clinical integration support and professional services for implementing brain vital signs assessments in clinical and performance settings.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise/Federal Healthcare Pricing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

NeuroCatch product offering

Product offering

Core offering

NeuroCatch develops and sells the NeuroCatch Platform, a portable EEG-based medical device that delivers objective cognitive brain function assessments in approximately 6 minutes at the point of care. The platform measures three event-related potentials (N100, P300, N400) extracted from EEG signals to quantify auditory sensation, basic attention, and cognitive processing. It is sold to healthcare providers, federal healthcare systems, sports organizations, military programs, and corporate wellness buyers.

Product overview

NeuroCatch offers a single unified medical device product called the NeuroCatch Platform. This flagship platform is a portable EEG-based system that delivers rapid, objective cognitive assessments in approximately 6 minutes at the point of care. The platform measures three specific event-related potentials (ERPs) - N100 for auditory sensation, P300 for basic attention, and N400 for cognitive processing - providing healthcare professionals with quantitative brain vital sign metrics. The NeuroCatch Platform is intended to be used in conjunction with other cognitive assessments and is not a standalone diagnostic tool for a specific brain health condition.

Differentiator

Problem solved

Functional benefit

Products and services

  • NeuroCatch Platform A portable, non-invasive EEG-based medical device that provides rapid (approximately 6-minute) objective cognitive assessments using the Brain Vital Signs framework. It measures three event-related potentials (N100 for auditory sensation, P300 for basic attention, N400 for cognitive processing) and is intended to be used in conjunction with other cognitive assessments. Registered with the Australian Register of Therapeutic Goods (ARTG 439393) and designated Rx only in the US.

Quantifiable outcome

  • Cognitive assessment completed in approximately 6 minutes at point of care
  • +2 more outcomes

Companies that use NeuroCatch

Customer profile

Named customers8 records

Segments5 records

Ideal customer profiles4 records

NeuroCatch technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

NeuroCatch partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and supporting.

  • Phoenix Bioscience CorecoreStrategic or Co-development Partner · 9 October 2025U.S. headquarters location at Phoenix Bioscience Core, a 30-acre medical and bioscience campus with Arizona's major universities, hospital systems, and research facilities. Supported by Greater Phoenix Economic Council (GPEC).
  • XLR8 PBC (Phoenix Bioscience Core)supportingStrategic or Co-development Partner · 10 September 2025Selected for Fall 2025 cohort of XLR8 PBC, a strategic launchpad program supporting health tech companies with access to industry leaders, mentorship, and strategic resources. Part of Phoenix's growing bioscience and medtech ecosystem.
  • Garibaldi Performance CentercoreStrategic or Co-development Partner · 9 September 2025Partnership with Whistler's new premier human optimization facility to provide cognitive assessment services at Crankworx Whistler 2025. NeuroCatch provided baseline assessments and brain vital signs for elite downhill mountain bike riders including Aaron Gwin, Dakotah Norton, and Frida Ronning.
  • Lovell Government ServicescoreChannel Partner/ Reseller/ Distributor · 14 August 2025Partnership with Service-Disabled Veteran-Owned Small Business (SDVOSB) to provide NeuroCatch Platform to major federal healthcare systems including Veterans Health Administration (VHA), Military Health System (MHS), and Indian Health Service (IHS). NeuroCatch Platform is now available on VA Federal Supply Schedule (FSS), GSA Advantage, and DLA Electronic Catalog (ECAT).
  • HealthTech Connex Inc.coreStrategic or Co-development PartnerRelated entity that developed the NeuroCatch Platform technology. Co-founder Dr. Ryan D'Arcy serves as President & CSO of both entities. HealthTech Connex operates the brain clinic where NeuroCatch technology was developed.
  • ASU/Mayo MedTech AcceleratorsupportingOthersNeuroCatch was an alumnus of the 2025 Arizona State University/Mayo Clinic MedTech Accelerator program, which helped advance the company's U.S. expansion and commercialization strategy.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

NeuroCatch competitors and assessment

Company assessment

Emerging players

  • Kernel: Kernel builds non-invasive brain-activity measurement hardware and cognitive performance tools. It is an emerging player in portable cognitive/neural monitoring and partially competes for the same premium cognitive performance and research buyers.
  • Muse (Interaxon): Muse sells a consumer EEG brain-sensing headband and accompanying meditation/cognitive apps. It is an emerging player in portable EEG with adjacent brain-health branding, but its regulatory pathway and customer base are consumer rather than clinical.
  • Emotiv: Emotiv builds consumer and research EEG headsets with associated cognitive and ERP analytics. It is an emerging player in portable EEG with overlapping neuroscience underpinnings, but skews toward consumer/wellness rather than clinical federal buyers.
  • Cumulus Neuroscience: Cumulus Neuroscience offers a cloud-enabled EEG platform that measures multiple cognitive biomarkers for clinical trials and CNS drug development. It overlaps with NeuroCatch on multi-ERP cognitive assessment but is more focused on pharma/biotech customers.

Broad incumbents

  • ANT Neuro: ANT Neuro is an established provider of EEG, EMG, and TMS equipment and software for research and clinical neurophysiology. It is a broad incumbent in the same EEG/ERP measurement category but with a much larger product portfolio and enterprise research focus.
  • MindMaze: MindMaze develops digital neurotherapeutics and brain-computer interface platforms for neurological recovery and cognitive assessment. It is a broad incumbent working in adjacent neurological assessment and rehabilitation markets.
  • Compumedics: Compumedics manufactures EEG, sleep diagnostic, and brain monitoring equipment sold globally to hospitals and researchers. It is a broad incumbent serving similar neurology and sleep customers with a wider hardware portfolio.

Direct peers

  • BrainScope: BrainScope develops EEG-based medical devices for objective assessment of traumatic brain injury and concussion in clinical and military settings. It directly competes with NeuroCatch in portable, point-of-care brain function assessment and shares the federal/military buyer profile.
  • SyncThink: SyncThink markets eye-tracking and VR-based objective concussion and balance assessment tools used by sports teams and clinicians. It competes with NeuroCatch for the same sports and military concussion/cognitive readiness budgets.
  • Advanced Brain Monitoring: Advanced Brain Monitoring produces EEG-based systems for sleep, cognitive performance, and neurological conditions. It is directly comparable to NeuroCatch on portable EEG, ERP-based cognitive assessment, and sports/military use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NeuroCatch social profiles

Digital presence

NeuroCatch compliance and trust

Trust signal

Compliance1 record

NeuroCatch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NeuroCatch leadership team

Management profile

Number of profiles

Profiles9 records

NeuroCatch funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NeuroCatch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroCatch

What does NeuroCatch do?

NeuroCatch develops and sells the NeuroCatch Platform, a portable EEG-based medical device that delivers objective cognitive brain function assessments in approximately 6 minutes at the point of care. The platform measures three event-related potentials (N100, P300, N400) extracted from EEG signals to quantify auditory sensation, basic attention, and cognitive processing. It is sold to healthcare providers, federal healthcare systems, sports organizations, military programs, and corporate wellness buyers.

Is NeuroCatch a public or private company?

NeuroCatch is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NeuroCatch founded?

NeuroCatch was founded in 2015. It employs 11 to 50 people.

Where is NeuroCatch based?

NeuroCatch is headquartered in Surrey, Canada, in the North America region.

How does NeuroCatch make money?

Three revenue lines are on record. NeuroCatch Platform Device Sales are the primary driver. The others are platform Software/Services and clinical/Professional Services.

Who are NeuroCatch's main competitors?

Emerging players on record are Kernel, Muse (Interaxon), Emotiv and Cumulus Neuroscience. Broad incumbents are ANT Neuro, MindMaze and Compumedics. Direct peers are BrainScope, SyncThink and Advanced Brain Monitoring.

Does NeuroCatch have an API?

No public API is recorded for NeuroCatch.

What industry is NeuroCatch in?

NeuroCatch's product category is Neurodiagnostic Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAA, General Neurology. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileNeuroCatch Inc. Announces Strategic Partnership with The Geneva Foundation to Advance Cognitive Health Research for Military PersonnelNeuroCatch Inc. announced a research partnership with The Geneva Foundation to advance cognitive health research for military personnel. The collaboration will use NeuroCatch's EEG-based platform to assess brain function in about six minutes. The partnership aims to improve cognitive resilience and performance among service members.KtarCanadian medtech company NeuroCatch opens in PhoenixCanadian medtech company NeuroCatch opened its U.S. headquarters in Phoenix on October 1 as part of the Arizona State University and Mayo Clinic MedTech Accelerator program. The company plans to expand its brain health manufacturing, sales, and clinical trials through 2026, hiring approximately 10 new employees over three years.PR NewswireNeuroCatch Partners with Gwin Racing to Boost Cognitive Performance in Downhill Mountain Biking with the New 'Elevate' ProgramNeuroCatch announced a partnership with Gwin Racing to integrate its cognitive performance program 'Elevate' into the elite downhill mountain biking team's training for the 2025 season. The program utilizes the NeuroCatch Platform to provide objective, non-invasive assessments of cognitive function including perception, attention, and processing speed to enhance reaction times, decision-making, and mental endurance. Five-time UCI World Cup Champion Aaron Gwin and rising star Michael Delesalle will participate, competing in the North American Pro Downhill Series, Crankworx events, and UCI World Cup races.PR NewswireNeuroCatch Introduces PeakSelect, Enabling a Deeper Clinical Dive into Brain Vital Signs at a Doctor's Office Near YouNeuroCatch Inc., a medical device company focused on objective brain health assessment, announced the release of PeakSelect on April 9, 2024, a software enhancement to their flagship NeuroCatch Platform that enables clinicians to perform deeper analysis of brain vital sign data for precision medicine. The tool measures cognitive function through event-related potentials in six minutes at the point of care and represents the first of planned software upgrades to advance brain health monitoring for conditions including concussions, dementias, and mental health. All existing NeuroCatch customers have already received the update remotely with reported positive reviews from clinical users.Global NewsEffects of smaller head impacts on young athletes studied with B.C.-made brain scannerResearchers from Simon Fraser University and the Mayo Clinic studied junior hockey players, fitting helmets with sensors and measuring brain waves over a season. They found a strong link between the number of impacts and cognitive impairment. The portable NeuroCatch device could enable new treatments and safer sport.Global NewsVolunteers needed to test video game to help children with neurodevelopmental disabilities - BCResearchers in B.C. and Alberta are developing Dino Island, a video game to help children with neurodevelopmental disabilities like autism. The program includes five games designed to improve attention and memory, with a self-adjusting difficulty level. Families can register online to participate in the study.Surrey Now-LeaderBasketball on the brain: Athletes monitored at Surrey clinic with NeuroCatch systemNorth Shore Basketball Academy players are having their brain function assessed at Surrey Neuroplasticity Clinic using the NeuroCatch device as part of a BBPO program. The clinic, opened in 2019, partners with the academy to measure cognitive and physical domains, aiming to optimize performance through deliberate practice.NeuroCatch Inc.NEUROCATCH INC. PARTNERS WITH BRAINFX ON NEURO HEALTH INNOVATIONNeuroCatch Inc. of Surrey, British Columbia and BrainFx of Pickering, Ontario announced a partnership on January 21, 2021 to share initiatives, best practices and collaborate on brain health, technology innovation, entrepreneurship and mutual promotion. NeuroCatch, a subsidiary of HealthTech Connex Inc., said the combination will give care providers objective, quantifiable insight into brain function. No financial terms were disclosed.Daily Hive VancouverBrain fog treatments for COVID-19 survivors being investigated in CanadaResearchers at Surrey Neuroplasticity Clinic are studying brain fog in COVID-19 survivors, tracking brainwaves to identify patterns. The study begins in January 2021, aiming to develop targeted treatments. Findings will be submitted for peer-reviewed publication.Global NewsAfter surviving attack in Afghanistan, B.C. man serves as inspiration for new centre for veterans - BCTrevor Greene, a B.C. veteran who survived an axe attack in Afghanistan, is now the inspiration for the Legion Veterans Village, Canada's first centre of excellence for veterans and first responders. The $312-million project, including 91 affordable rental units, is expected to open in 2022.